Marine Protein Hydrolysate as Dietary Supplement in Elderly Part I (MPH-BS)

Helse Møre og Romsdal HF

Status

Completed

Conditions

Healthy Volunteers

Treatments

Dietary Supplement: Control

Dietary Supplement: Marine protein hydrolysate (mph)

Study type

Interventional

Funder types

Other

Identifiers

NCT03669796

2017/1794

Details and patient eligibility

About

The aim of this study is to investigate the potential effect of a marine protein hydrolysate (MPH) supplement before a meal on postprandial glucose tolerance in healthy subjects, to achieve more knowledge on this presumed beneficial, blood glucose lowering effect

Full description

To further investigate the effects of MPH in a single dose of 20 mg/kg of body weight on postprandial blood glucose, insulin and GLP-1 (as markers of glucose metabolism) in healthy, active middle-aged to elderly subjects - age 40-65 years.

Enrollment

41 patients

Sex

All

Ages

40 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Signed informed consent
Body mass index (BMI) 20-30

Exclusion criteria

Suspected allergies against fish or shellfish
Low or unstable blood pressure
Diabetes mellitus, treated pharmacological
Chronic diseases or therapies that is likely to interfere with the evaluation of study results
Acute infections (may be reconsidered for inclusion at a later time)
Allergic to milk, confirmed diagnose
Pregnancy
Women who are breast-feeding infants
Inability or unwillingness to comply with the requirements of study procedures